Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol on Cerebral Autoregulation
NCT05533580Unknown
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Oct 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Differences in dynamic cerebral blood flow autoregulation. Status: unknown.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05533580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05533580.